QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

CLOV

QT77Clover Health Investments, Corp.
NASDAQ·Healthcare·Medical - Healthcare Plans·USA
Latest market price
5.00
+0.20+4.17%
OverviewShort InterestFilings
CLOVQT77Clover Health Investments, Corp.·NASDAQ
OverviewShort InterestFilings
5.00+4.17%
TA
Loading chart...
Screen all →
UNH+0.36%$400.96CVS-0.85%$98.32ELV-0.71%$388.50CI-2.04%$279.27HUM-0.37%$360.65CNC+0.63%$61.02MOH-0.08%$195.37OSCR+0.46%$28.40
Snapshot
Index-P/E-EPS (ttm)-0.11
Insider Own48.92%
Shs Outstand526.68M
Perf Week2.04%
Market Cap2.49BForward P/E98.75EPS next Y0.05Insider Trans1.78%Shs Float-Perf Month42.86%
Enterprise Value2.31BPEG0.57EPS next Q0.05Inst Own-Short Float-Perf Quarter164.55%
Income-56469279.00P/S1.13EPS this Y135.21%Inst Trans-Short Ratio-Perf Half Y89.39%
Sales2.21BP/B7.38EPS next Y30.72%ROA-8.16%Short Interest-Perf YTD112.77%
Book/sh0.65P/C43.78EPS next 5Y63.97%ROE-17.08%52W High5.18 -3.47%Perf Year76.68%
Cash/sh0.63P/FCF45.61EPS past 3/5Y-ROIC-15.76%52W Low1.58 216.46%Perf 3Y-
Dividend Est.-EV/EBITDA-41.92Sales past 3/5Y20.60% 23.38%Gross Margin18.39%Volatility4.29% 4.67%Perf 5Y-
Dividend TTM-EV/Sales1.05EPS Y/Y TTM100.00%Oper. Margin-2.57%ATR (14)0.29Perf 10Y-
Dividend Ex-Date-Quick Ratio1.33Sales Y/Y TTM61.34%Profit Margin-2.58%RSI (14)72.47Recom3.22
Dividend Gr. 3/5Y-Current Ratio1.33EPS Q/Q40.00%SMA2019.18%Beta1.18Target Price4.47
Payout0.00%Debt/Eq0.00Sales Q/Q62.12%SMA5051.68%Rel Volume0.92Prev Close4.80
Employees570LT Debt/Eq0.01EarningsAug 04SMA20084.65%Avg Volume7.71MPrice5.00
IPO DateJun 12, 2020Option/ShortYes / YesEPS/Sales Surpr.0.00% 4.76%Net Debt/EBITDA3.14Volume7,117,133Change4.17%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-11-26ReiteratedUBSNeutral$4.75
Jun-04-26ReiteratedCanaccord GenuityBuy$2.50 → $4.20
Oct-21-25ReiteratedLeerink Partners$3.00
Dec-17-24InitiatedCraig-HallumBuy$6.00
Aug-06-24ReiteratedCanaccord GenuityBuy$2.50
Nov-16-22ReiteratedCitigroupNeutral$1.80
Feb-02-22UpgradeCowen & Co.Underperform → Market Perform
Jan-07-22DowngradeCredit SuisseNeutral → Underperform
Jul-12-21DowngradeJP MorganNeutral → Underweight
Jun-10-21DowngradeB of A SecuritiesNeutral → Underperform
Latest News
Jun-18-26
Jun-18-2608:23AM
Cramer Gives Vistra His Blessing, Backs Stryker, Steers Clear Of AI-Exposed FICOBenzinga
Jun-16-26
Jun-16-2604:13PM
Clover Health Investments' Clover Care Services CEO Brady Priest Stepping Down; Co. Integrating Its Home-Care Business With Its Broader Operations; Not Appointing Priest's SuccessorBenzinga
Jun-11-26
Jun-11-2602:02PM
UBS Maintains Neutral on Clover Health Investments, Raises Price Target to $4.75Benzinga
02:02PM
UBS Maintains Neutral on Clover Health Investments, Raises Price Target to $4.75Benzinga
07:32AM
Clover Health Stock Extends Gains After Court Forces CMS to Upgrade Medicare Star RatingBenzinga
07:32AM
Clover Health Stock Extends Gains After Court Forces CMS to Upgrade Medicare Star RatingBenzinga
Jun-10-26
Jun-10-2601:05PM
12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga
09:58AM
Caseys General Stores Upbeat Q4 Earnings, Joins Applied Optoelectronics, Clover Health Investments And Other Big Stocks Moving Higher On WednesdayBenzinga
08:40AM
Clover Health Announces That Its 2026 Star Rating Has Been Recalculated At 4.5 Following U.S. Court's Summary JudgementBenzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue2,2121,9241,371
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A1,8041,5681,006
Gross Profit407356365
Selling, General and Administrative Excl. Other199176409
Research and Development
000
Other Operating Expense2652652
Operating Income-57-86-46
Interest Expense000
Unusual Expense
———
Non-Operating Income (Expense)001
Net Income Before Taxes-57-86-46
Income Taxes
000
Consolidated Net Income-57-86-43
Net Income From Continuing Operations-57-86-46
Net Income-57-86-43
EPS (Recurring)-0.11-0.17-0.09
EPS (Basic, Before Extraordinaries)-0.11-0.17-0.09
EPS (Diluted)-0.11-0.17-0.09
EBITDA-55-84-45
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio1.180.63—
Gross Margin18.4018.5026.62
Operating Margin-2.58-4.47-3.36
Net Margin-2.58-4.47-3.14
Shares Outstanding522517490
Market Capitalization2,6101,215—
Operating Lease Expense
———
Insider Trading Volume
$5.31$4.92$4.53$4.13$3.74● Close Price0.00M0.36M0.73M1.09M1.45MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Reynoso Jamie L.CEO, Medicare AdvantageJun 17 '26Sale4.782,36011,2812,841,211Jun 18 12:00 AM
OLDAKOWSKI JOSEPH FRANKVP OF FINANCE AND CONTROLLERJun 16 '26Sale4.8612,10258,816299,067Jun 17 12:00 AM
Soares KarenChief Legal OfficerJun 15 '26Sale4.614,68121,5791,567,741Jun 16 12:00 AM
Reynoso Jamie L.CEO, Medicare AdvantageJun 15 '26Sale4.616,35029,2742,843,571Jun 16 12:00 AM
Reynoso Jamie L.CEO, Medicare AdvantageJun 11 '26Sale4.917,28935,7892,849,921Jun 11 12:00 AM
Wai ConradCEO, Counterpart HealthMay 28 '26Sale3.99220,426879,5001,390,056May 28 12:00 AM
Edwards Carladenise ArmbristerDirectorMay 18 '26Sale3.4267,160229,687285,432May 19 12:00 AM
Priest Brady PatrickCEO of Clover Care ServicesMay 13 '26Sale3.5298,039345,0972,040,222May 13 12:00 AM
Reynoso Jamie L.CEO, Medicare AdvantageMar 18 '26Sale1.915,83311,1412,716,735Mar 18 12:00 AM
Priest Brady PatrickCEO of Home CareMar 04 '26Sale2.17175,000379,7501,998,584Mar 05 12:00 AM
Reynoso Jamie L.CEO, Medicare AdvantageJan 20 '26Sale2.584,59711,8602,737,700Jan 20 12:00 AM
Garipalli Vivekdirector, 10 percent owner:Jan 07 '26Option Exercise0.009,997,296010,247,042Jan 09 12:00 AM
Reynoso Jamie L.CEO, Medicare AdvantageJan 07 '26Sale2.532,1025,3182,757,029Jan 07 12:00 AM
Reynoso Jamie L.CEO, Medicare AdvantageDec 18 '25Sale2.614,91312,8232,767,240Dec 18 12:00 AM
Reynoso Jamie L.CEO, Medicare AdvantageNov 04 '25Sale3.5830,385108,7782,793,411Nov 05 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR